About Ceptaris Therapeutics
Ceptaris Therapeutics is a company based in Malvern (United States) founded in 2002 was acquired by Actelion in July 2013.. Ceptaris Therapeutics has raised $49.04 million across 10 funding rounds from investors including SVB, Actelion and HHS.
- Headquarter Malvern, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ceptaris Therapeutics
Ceptaris Therapeutics has successfully raised a total of $49.04M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $10.0M
-
First Round
First Round
(01 Jun 2002)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2012 | Amount | Series D - Ceptaris Therapeutics | Valuation | Palo Alto Investors , Burrill and Company |
|
| Feb, 2012 | Amount | Debt – Conventional - Ceptaris Therapeutics | Valuation |
investors |
|
| Aug, 2011 | Amount | Series D - Ceptaris Therapeutics | Valuation | Burrill and Company , Aperture Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ceptaris Therapeutics
Ceptaris Therapeutics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Actelion and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare sector investments are managed through private equity strategies.
|
Founded Year | Domain | Location | |
|
A healthcare-focused investment firm supporting innovative company growth.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ceptaris Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ceptaris Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ceptaris Therapeutics Comparisons
Competitors of Ceptaris Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Ceptaris Therapeutics
When was Ceptaris Therapeutics founded?
Ceptaris Therapeutics was founded in 2002.
Where is Ceptaris Therapeutics located?
Ceptaris Therapeutics is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Is Ceptaris Therapeutics a funded company?
Ceptaris Therapeutics is a funded company, having raised a total of $49.04M across 10 funding rounds to date. The company's 1st funding round was a Series D of $14.4M, raised on Jun 01, 2002.
What does Ceptaris Therapeutics do?
Ceptaris Therapeutics was founded in 2002 and headquartered in Malvern, United States, as a clinical-stage biopharmaceutical company. Focus was placed on developing Mechlorethamine gel, marketed as Valchlor, for treating early-stage (I-IIA) mycosis fungoides, a form of cutaneous T-cell lymphoma. Operations centered on oncology therapeutics until acquisition by Actelion in 2013, following FDA rejection of the drug application the prior year. The company was previously known as Yaupon.
Who are Ceptaris Therapeutics's investors?
Ceptaris Therapeutics has 12 investors. Key investors include SVB, Actelion, HHS, Oxford Finance, and Burrill and Company.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.